查找临床试验
已按「多发性骨髓瘤」检索，对应国际通用词 multiple myeloma
共找到 585 项正在招募的试验
数据更新于 23:04，每 5 分钟自动同步A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
United States、France、Italy、Poland、Spain 等 6 国
年龄 18 Years – 不限
C4 Therapeutics, Inc.
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
United States
年龄 18 Years – 不限
Washington University School of Medicine
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
United States
年龄 18 Years – 75 Years
Benjamin T Diamond, MD
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
United States、Bosnia and Herzegovina、Bulgaria、Croatia、Hungary 等 8 国
年龄 18 Years – 不限
Grifols Therapeutics LLC
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
United States
年龄 18 Years – 不限
Memorial Sloan Kettering Cancer Center
Universal CAR-T Cell Therapy for MM
China
年龄 18 Years – 不限
Bioray Laboratories
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
United States
年龄 30 Years – 不限
Wake Forest University Health Sciences
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
United States
年龄 18 Years – 不限
Massachusetts General Hospital
Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma
United States
年龄 18 Years – 不限
CellCentric Ltd.
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
United States
年龄 18 Years – 不限
University of Alabama at Birmingham
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
United States、Argentina、Australia、Brazil、China 等 12 国
年龄 18 Years – 不限
GlaxoSmithKline
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
United States
年龄 18 Years – 不限
Medical College of Wisconsin